PRIME’s technology for the development of novel veterinary vaccines
Boehringer Ingelheim and Biotech Startup enter a strategic collaboration
29-Nov-2021 -
Prime Vector Technologies (PRIME), a Biotech Startup focusing on the development of viral vector based vaccines, and Boehringer Ingelheim, a leading global research-based pharmaceutical company, announce that they have entered a strategic collaboration, option and licence agreement. The ...
animal health
vaccines
veterinary vaccines
+1